Accuracy of cervical cytology: Comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway

BMC Clinical Pathology

Volumn 17, Issue 1, 2017, Pages

  Sørbye, Sveinung Wergeland ^a   Suhrke, Pål ^b   Revå, Berit Wallem ^b   Berland, Jannicke ^c   Maurseth, Ramona Johansen ^d   Al Shibli, Khalid ^d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b VESTFOLD HOSPITAL TRUST   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85028548916     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/s12907-017-0058-8     Document Type: Article

References (18)

1. Munoz N, Bosch FX, de SS, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
3. de Blasio BF, Neilson AR, Klemp M, Skjeldestad FE. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era. J Public Health (Oxf). 2012;34:539-47.
4. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-42.
5. Skare GB, Lonnberg S, Bjorge T, Trope A: The Norwegian cervical cancer screening programme. Annual report 2015. The Cancer Registry of Norway 2016.
6. Andreassen T, Vogt C. Screening for cervical cancer - future perspectives. Tidsskr Nor Laegeforen. 2014;134:1122-3.
7. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst. 2004;96:280-93.
8. Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP et al.: Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 2013, 3: CD008054.
9. Bigras G, Wilson J, Russell L, Johnson G, Morel D, Saddik M. Interobserver concordance in the assessment of features used for the diagnosis of cervical atypical squamous cells and squamous intraepithelial lesions (ASC-US, ASC-H, LSIL and HSIL). Cytopathology. 2013;24:44-51.
10. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663-72.
11. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-5.
12. Wright TC Jr, Stoler MH, Behrens CM, Sharma A, Sharma K, Apple R. Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial. Int J Cancer. 2014;134:1835-43.
13. Wright TC Jr, Stoler MH, Aslam S, Behrens CM. Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study. Am J Clin Pathol. 2016;146:391-8.
14. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2012;2013(121):829-46.
15. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754.
16. Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, et al. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J Clin Oncol. 2012;30:3044-50.
17. Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev. 2008;17:3033-42.
18. Sorbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES. Triage of women with low-grade cervical lesions - HPV mRNA testing versus repeat cytology. PLoS One. 2011;6:e24083.